Prosecution Insights
Last updated: April 19, 2026
Application No. 18/446,409

TISSUE ANCHORS AND TECHNIQUES FOR USE THEREWITH

Non-Final OA §102
Filed
Aug 08, 2023
Examiner
DORNBUSCH, DIANNE
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Edwards Lifesciences Innovation (Israel) Ltd.
OA Round
1 (Non-Final)
73%
Grant Probability
Favorable
1-2
OA Rounds
4y 1m
To Grant
99%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allow Rate
544 granted / 741 resolved
+3.4% vs TC avg
Strong +36% interview lift
Without
With
+35.5%
Interview Lift
resolved cases with interview
Typical timeline
4y 1m
Avg Prosecution
24 currently pending
Career history
765
Total Applications
across all art units

Statute-Specific Performance

§101
1.2%
-38.8% vs TC avg
§103
39.3%
-0.7% vs TC avg
§102
33.1%
-6.9% vs TC avg
§112
19.0%
-21.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 741 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group a (Anchor) Species i (Fig. 1a-4b and only the anchor (120) of Fig. 25a-f, 26a-b, 27a-c, 28a-b, 49a-d, and 54-55c), Group b (handling system) Species ii (Fig. 20a-21e), Group c (Tensioner) Species I (Fig. 22a-b), and Group d (anchor delivery) Species x (Fig. 54-55c) in the reply filed on 11/24/25 is acknowledged. Claims 579 and 582 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected species, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 11/24/25. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 565, 574, and 575 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Saadat et al. (2005/0251177). Saadat discloses the following claimed limitations: Claim 565: A system for use with a subject, comprising: a catheter device (60) (Fig. 4, 5a, and 13-15b, [0049], and [0076]) , comprising: a tube (64) (Fig. 4-5a and 13) that has: a distal opening (72 as seen in Fig. 5a where anchor 68 exits as seen in Fig. 8d) that is configured to be transluminally advanced into the subject (Fig. 6-8d where it is capable of performing this function), and a proximal end (70) that defines a proximal opening (Fig. 5a-b), and an extracorporeal unit (400) (Fig. 15a-15b) that is coupled to the proximal end of the tube (Fig. 13-15b and [0076] where the handle of the two devices of Fig. 4-5 are joined to form handle 200); and a series of anchors (68) (Fig. 15a-15b); a series of cartridges (300) (Fig. 15a-15b and [0091]) arranged along the extracorporeal unit (Fig. 15a-15b), each of the cartridges: having an initial position (Fig. 15a where the initial position is inside the casing 400) in which the cartridge holds a respective anchor (68) of the series of anchors (Fig. 15a-15b and [0091]), while remaining coupled to the extracorporeal unit (Fig. 15a-15b and [0090-93]), being moveable from the initial position to a deployment position ( where it is placed inside the handle Fig. 15a-15b and [0090-93]); and an anchor driver (76) that is configured to, for each of the anchors, sequentially: engage the anchor (Fig. 15b, [0082] and [0091-93]), and while the respective cartridge is in the deployment position (Fig. 15b, [0082] and [0091-93]), move the anchor out of the respective cartridge, through the proximal opening, and through the tube toward the distal opening (Fig. 15b, [0082] and [0091-93]). Claim 574: wherein each of the cartridges is removable from the extracorporeal unit (Fig. 15a-b and [0091-93]). Claim 575: wherein the anchor driver is configured to, for each of the anchors, move the anchor out of the respective cartridge, through the proximal opening, and through the tube toward the distal opening while the respective cartridge remains in the deployment position (Fig. 15a-b and [0091-93]). Allowable Subject Matter Claims 566-573, 576-578, 580-581, and 583-589 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The examiner tried to contact the attorney of record on 1/15/26 and 1/16/26 regarding a possible examiner’s amendment however the examiner was unable to reach the attorney. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. The cited prior art when considered alone or in combination does not anticipate or make obvious the limitations of the objected claims. Any inquiry concerning this communication or earlier communications from the examiner should be directed to DIANNE DORNBUSCH whose telephone number is (571)270-3515. The examiner can normally be reached Monday-Wednesday 9 am-3 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Elizabeth Houston can be reached at (571) 272-7134. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DIANNE DORNBUSCH/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Aug 08, 2023
Application Filed
Jan 20, 2026
Non-Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594139
DEVICES AND METHODS TO ACCESS A TARGET WITHIN THE BODY
2y 5m to grant Granted Apr 07, 2026
Patent 12582395
METHOD AND APPARATUS FOR FORMING A SELF-LOCKING ADJUSTABLE LOOP
2y 5m to grant Granted Mar 24, 2026
Patent 12575820
SURGICAL FIXATION SYSTEMS AND METHODS
2y 5m to grant Granted Mar 17, 2026
Patent 12569243
SYSTEMS FOR PERCUTANEOUS VENTRICULOPLASTY USING VENTRICULAR ANCHORS
2y 5m to grant Granted Mar 10, 2026
Patent 12558099
DEVICES, TREATMENTS AND METHODS TO RESTORE TISSUE ELASTIC RECOIL
2y 5m to grant Granted Feb 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
73%
Grant Probability
99%
With Interview (+35.5%)
4y 1m
Median Time to Grant
Low
PTA Risk
Based on 741 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month